GB9526691D0 - Medical use of proteases - Google Patents
Medical use of proteasesInfo
- Publication number
- GB9526691D0 GB9526691D0 GBGB9526691.2A GB9526691A GB9526691D0 GB 9526691 D0 GB9526691 D0 GB 9526691D0 GB 9526691 A GB9526691 A GB 9526691A GB 9526691 D0 GB9526691 D0 GB 9526691D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- proteases
- medical use
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21004—Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22002—Papain (3.4.22.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526691.2A GB9526691D0 (en) | 1995-12-29 | 1995-12-29 | Medical use of proteases |
ZA9610433A ZA9610433B (en) | 1995-12-29 | 1996-12-11 | Medical use of proteases. |
EP96942449A EP0876153A2 (en) | 1995-12-29 | 1996-12-13 | Medical use of proteases |
JP9524091A JP2000502697A (en) | 1995-12-29 | 1996-12-13 | Use of proteases in medicine |
AU11818/97A AU1181897A (en) | 1995-12-29 | 1996-12-13 | Medical use of proteases |
PCT/GB1996/003089 WO1997024138A2 (en) | 1995-12-29 | 1996-12-13 | Medical use of proteases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526691.2A GB9526691D0 (en) | 1995-12-29 | 1995-12-29 | Medical use of proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9526691D0 true GB9526691D0 (en) | 1996-02-28 |
Family
ID=10786186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9526691.2A Pending GB9526691D0 (en) | 1995-12-29 | 1995-12-29 | Medical use of proteases |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0876153A2 (en) |
JP (1) | JP2000502697A (en) |
AU (1) | AU1181897A (en) |
GB (1) | GB9526691D0 (en) |
WO (1) | WO1997024138A2 (en) |
ZA (1) | ZA9610433B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1252101A (en) | 1997-02-25 | 2000-05-03 | 科特克斯(英国)有限公司 | Component of bromelain |
US20020102253A1 (en) | 1997-02-25 | 2002-08-01 | Mynott Tracey Lehanne | Component of bromelain |
DE19726244C2 (en) * | 1997-06-20 | 2000-03-02 | Mucos Pharma Gmbh & Co | Use of proteolytic enzymes and rutoside to prevent or treat graft rejection |
DE19726255C2 (en) * | 1997-06-20 | 2000-03-16 | Mucos Pharma Gmbh & Co | Influence of cytokines by proteolytic enzymes and rutoside |
DE19726254C2 (en) * | 1997-06-20 | 1999-10-21 | Mucos Pharma Gmbh & Co | Tolerance induction through proteases |
DE19957318A1 (en) * | 1999-11-29 | 2001-06-21 | Mucos Pharma Gmbh & Co | Influence of TGF-beta by proteolytic enzymes |
DE10018980A1 (en) * | 2000-04-17 | 2001-11-08 | Mucos Pharma Gmbh & Co | Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9412711D0 (en) * | 1994-06-24 | 1994-08-17 | Cortecs Ltd | Medical use of bromelain |
-
1995
- 1995-12-29 GB GBGB9526691.2A patent/GB9526691D0/en active Pending
-
1996
- 1996-12-11 ZA ZA9610433A patent/ZA9610433B/en unknown
- 1996-12-13 EP EP96942449A patent/EP0876153A2/en not_active Withdrawn
- 1996-12-13 AU AU11818/97A patent/AU1181897A/en not_active Abandoned
- 1996-12-13 JP JP9524091A patent/JP2000502697A/en active Pending
- 1996-12-13 WO PCT/GB1996/003089 patent/WO1997024138A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1181897A (en) | 1997-07-28 |
JP2000502697A (en) | 2000-03-07 |
EP0876153A2 (en) | 1998-11-11 |
WO1997024138A3 (en) | 1997-10-16 |
WO1997024138A2 (en) | 1997-07-10 |
ZA9610433B (en) | 1998-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1445259T1 (en) | Use of crystal forms of 2-methyl-thieno-benzodiazepine | |
GB9526560D0 (en) | Use of 2-Amino-Heterocycles | |
ZA943047B (en) | Human osteoclast-derived cathepsin | |
IL114331A0 (en) | Medical use of bromelain | |
GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
HU9700071D0 (en) | Use of muramilpeptides | |
ZA96725B (en) | Use of phenyclyclohexylcarboxamides | |
SG42309A1 (en) | Medical use of enzymes | |
IL113992A0 (en) | Use of copolymer-1 | |
GB9526691D0 (en) | Medical use of proteases | |
HUP9901448A3 (en) | Novel medical use | |
ZA951485B (en) | Medical application of bromelain | |
AU5697996A (en) | Peptidyl compounds and their therapeutic use | |
HUP9800272A3 (en) | Use of penciclovir for the treatment of human herpes-virus-8 | |
PL319344A1 (en) | Gene of human galactokinase | |
IL118225A0 (en) | Use of felodipine | |
GB9523066D0 (en) | Compounds and their therapeutic use | |
IL117844A0 (en) | Use of (s)-adenosyl-l-methionine | |
GB9313189D0 (en) | Medical use of enzymes | |
GB9308164D0 (en) | Medical use of enzymes | |
GB9502739D0 (en) | Diagnosis of toxicoinfections clostridiosis | |
GB9523473D0 (en) | Diagnosis of toxicoinfectious clostridiosis | |
PL319345A1 (en) | Gene of human galactokinase | |
GB9213862D0 (en) | Medical use of enzymes | |
ZA963738B (en) | Peptidyl compounds and their therapeutic use |